Company: STAA
Filing Date: 2025-10-02
Form Type: DFAN14A
Source: 0001213900-25-095514
Chunk: 24

Company: STAAR SURGICAL CO
Filing Date: 2025-10-02
Form: DFAN14A
Chunk 24
---
…” Macroeconomic Headwinds “The level of inventory owned by our distributors in China has decreased substantially since December 27, 2024, and has now returned to historical levels .” 3 “Broadwood’s outlook did not appropriately account for risks and challenges regarding… the utilization of inventory at distributors…” Inventory Levels “Our perspective is this trade war situation, we believe, is a transitory issue . So, we expect that over time to pass…. The reality is we’ve substantially mitigated the tariff risk because we’ve got inventory in - market that’s going to get us through the end of this year, early next [year].” 4 “[T]he Board considered additional risks and opportunities that could affect STAAR’s standalone business plan, including… a potential trade war and related tariff risks…” Tariffs “[O] ur short - term tactical challenges will mostly be addressed by the end of Q2 … [W]e operate in a very large and growing market, so we will generally enjoy tailwinds [in the future] …” 2 “We believe the value provided by the Alcon merger exceeds what STAAR could achieve on a standalone basis in the foreseeable future, particularly given STAAR’s lower growth rate and the resulting impact on its valuation…” STAAR’s Long - Term Prospects 1. Source: STAAR proxy statement on Form DEFM14A, filed with the SEC on September 16, 2025. 2. Source: STAAR Q1 2025 Earnings Call, May 7, 2025. 3. Source: STAAR Quarterly Report on Form 10 - Q for the period ended June 27, 2025. 4. Source: William Blair Growth Stock Conference, June 4, 2025. 5 B

Broadwood Partners, L.P. Net Sales in China ($M) 1 STAAR’s Latest Remarks on China Are Disingenuous 34 1. Source: STAAR Investor Presentation, filed with the SEC on September 26, 2025. 2. Source: William Blair Growth Stock Conference, June 4, 2025. 3. Source: STAAR Q1 2025 Earnings Call, May 7, 2025. Management’s own prior statements demonstrate that China remains a promising market What STAAR Has Recently Said Recently Elsewhere About China What STAAR Is Saying About China in Its Latest Presentation 1 Topic “That's where a lot of the myopia patients